SOX2 and prostate cancer: Knockout of the Sox2 leads to suppression of the activity of the miR-452-5p/HMGB3 signaling axis and can cause inactivation of the Wnt/β-catenin signaling pathway, which can effectively slow the growth and metastasis of prostate cancer cells [236].